Position in LH
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$633,920
+$27,728 QoQ
Shares Held
2,264
-0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#533
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bryn Mawr Trust Advisors, LLC holds $33,326,657 across 8 Diagnostics & Research names. LH ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
91,007 | $17,335,013 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
10,158 | $5,347,577 | |
| 3 | A |
Agilent Technologies, Inc.
|
32,301 | $4,290,541 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
4,936 | $2,474,712 | |
| 5 | WAT |
Waters Corp /De/
|
6,268 | $2,350,750 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
2,264 | $633,920 | |
| 7 | DGX |
Quest Diagnostics Inc
|
2,283 | $483,881 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,809 | $410,263 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $633,920 | 2,264 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $606,192 | 2,272 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $424,488 | 1,692 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $594,788 | 2,072 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $542,608 | 2,067 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $478,280 | 2,055 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $474,692 | 2,070 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $221,021 | 989 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||